Ugandan Scientist Dr. Magoola Set to Revolutionize Livestock Industry with World’s First Universal Vaccine for Foot and Mouth Disease
Kampala, Uganda — In a groundbreaking achievement, Dr. Matthias Magoola, Founder and Managing Director of Dei BioPharma, has been granted a patent acceptance by the United States Patent and Trademark Office for his invention of the world’s first universal vaccine against Foot and Mouth Disease (FMD), a highly contagious viral infection affecting livestock worldwide.
This innovative vaccine, titled “Affordable Universal Fusion Universal Vaccine for Foot and Mouth Disease Infections,” has the potential to save the Ugandan government billions of shillings spent on importing vaccines annually. More importantly, it will provide a cost-effective solution for livestock farmers, enhancing food security and economic growth.
Dr. Magoola’s vaccine combines the epitopes of all known FMD virus serotypes, inducing cross-protection against multiple strains. This pioneering technology has far-reaching implications for the global livestock industry, making Uganda a hub for vaccine production and export.
The patent acceptance is a testament to Dr. Magoola’s tireless efforts in vaccine research and development.
His work has been recognized internationally, with recent awards including the prestigious International Molecular Biologist Award and nomination as one of the upcoming pharmaceutical CEOs to watch in 2025.
With over 100 patents filed in the USA for various diseases and vaccines, Dr. Magoola is poised to revolutionize the pharmaceutical industry.
His commitment to using cutting-edge mRNA technology to develop affordable and effective treatments has the potential to transform the lives of millions worldwide.
